Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge

Journal of Virology

Volumn 77, Issue 13, 2003, Pages 7486-7491

  Fischer, D ^a,c   Rood, D ^a   Barrette, R W ^a   Zuwallack, A ^a   Kramer, E ^b   Brown, F ^b   Silbart, L K ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; FOOT AND MOUTH DISEASE VIRUS PEPTIDE; HUMORAL ANTIBODY; KEYHOLE LIMPET HEMOCYANIN; NEUTRALIZING ANTIBODY; SECRETORY IMMUNOGLOBULIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GUINEA PIG; IMMUNITY; IMMUNIZATION; NONHUMAN; NOSE SECRETION; PRIORITY JOURNAL; UPPER RESPIRATORY TRACT; VACCINATION;

ADMINISTRATION, INTRANASAL; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; FEMALE; FOOT-AND-MOUTH DISEASE VIRUS; GUINEA PIGS; IMMUNITY, MUCOSAL; IMMUNODOMINANT EPITOPES; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; VIRAL VACCINES;

EID: 0038805626     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.13.7486-7491.2003     Document Type: Article

References (42)

1. Acharya, R., E. Fry, D. Stuart, G. Fox, D. Rowlands, and F. Brown. 1989. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Angstroms resolution. Nature 337:709-716.
2. Barnes, G. L., J. S. Lund, S. V. Mitchell, L. DeBruyn, L. Piggford, A. L. Smith, J. Furmedge, P. J. Masendycz, H. C. Bugg, N. Bogdonavic-Sakran, J. B. Carlin, and R. F. Bishop. 2002. Early phase II trial of human rotavirus vaccine candidate RV3. Vaccine 20:2950-2956.
3. 24 Cruzeiro strain of foot-and-mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence. J. Gen. Virol. 77:1011-1018.
4. Belyakov, I. M., M. A. Derby, J. D. Ahlers, B. L. Kelsall, P. Earl, B. Moss, W. Strober, and J. A. Berzofsky. 1998. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc. Natl. Acad. Sci. USA 95:1709-1714.
5. Bessen, D., and V. A. Fischetti. 1988. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect. Immun. 56:2666-2672.
6. Bessen, D., and V. A. Fischetti. 1990. Synthetic peptide vaccine against mucosal colonization by group A streptococci. J. Immunol. 145:1251-1256.
7. Beyer, W. E., A. M. Palache, J. C. de Jong, and A. D. Osterhaus. 2002. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine 20:1340-1353.
8. Bittle, J. L., R. A. Houghten, H. Alexander, T. M. Shinnick, J. G. Sutcliffe, R. A. Lerner, D. J. Rowlands, and F. Brown. 1982. Protection against FMD by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature (London) 298:30-33.
9. Briand, J. P., N. Benkirane, G. Guichard, J. F. E. Newman, M. H. V. Van Regenmortel, F. Brown, and S. Muller. 1997. A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies. Proc. Natl. Acad. Sci. USA 94:12545-12550.
10. Brown, F. 1994. The Leeuwenhoek lecture, 1993. Peptide vaccines: dream or reality? Philos. Trans. R. Soc. Lond. E 344:213-219.
11. Brown, F. 1995. Antibody recognition and neutralization of foot-and-mouth disease virus. Virology 6:243-248.
12. Brown, F. 1999. Foot-and-mouth disease and beyond: vaccine design, past, present and future. Arch. Virol. (Suppl.) 15:179-188.
13. Casal, J. I., J. P. Langeveld, W. W. Schaapper, E. van Dijk, C. Vela, S. Kamstrup, and R. H. Meloen. 1995. Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence. J. Virol. 69:7274-7277.
14. DiMarchi, R., G. Brooke, C. Gale, V. Cracknell, T. Doel, and N. Mowat. 1986. Protection of cattle against food-and-mouth disease by a synthetic peptide. Science 232:639-641.
15. Doel, T. R. 1996. Natural and vaccine-induced immunity to foot and mouth disease: the prospects for improved vaccines. Rev. Sci. Tech. Off. Int. Epizoot. 15:883-911.
16. Doel, T. R., C. Gale, C. M. C. F. Do Amaral, G. Mulcahy, and R. DiMarchi. 1990. Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus. J. Virol. 64:2260-2264.
17. Doel, T. R., L. Williams, and P. V. Barnett. 1994. Emergency vaccination against foot-and-mouth disease: rate of development of immunity and implications for the carrier state. Vaccine 12:592-600.
18. Dunn, C. S., A. R. Samuel, L. A. Pullen, and J. Anderson. 1998. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease. Virology 247:51-61.
19. Elson, C. O., and W. Ealding. 1984. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 133:2892-2897.
20. Elson, C. O., and W. Ealding. 1984. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132:2736-2741.
21. Hartman, A. B., L. L. Van Der Verg, and M. M. Venkatesan. 1999. Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines. Infect. Immun. 67:5841-5847.
22. Leist, T. P., S. P. Cobbold, H. Waldmann, M. Aguet, and R. M. Zinkernagel. 1987. Functional analysis of T lymphocyte subsets in antiviral host defense. J. Immunol. 138:2278-2281.
23. Lycke, N., U. Karlsson, A. Sjölander, and K.-E. Magnusson. 1991. The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand. J. Immunol. 33:691-698.
24. Mateu, M. G., D. Andreu, and E. Domingo. 1995. Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus. Virology 210:120-127.
25. McCullough, K. C., L. Bruckner, R. Schaffner, W. Fraefel, and U. Kihm. 1992. Relationship between anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection. Vet. Microbiol. 30:99-112.
26. McCullough, K. C., F. De Simone, E. Brocchi, L. Capucci, J. R. Crowther, and U. Kihm. 1992. Protective immune response against foot-and-mouth disease. J. Virol. 66:1835-1840.
27. McCullough, K. C., D. Parkinson, and J. R. Crowther. 1988. Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology 65:187-191.
28. McCullough, K. C., L. Pullen, and D. Parkinson. 1992. The immune response against foot-and-mouth disease virus: influence of the T lymphocyte growth factors IL-1 and IL-2 on the murine humoral response in vivo. Immunol. Lett. 31:41-46.
29. Morgan, D. O., and D. M. Moore. 1990. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines. Am. J. Vet. Res. 51:40-45.
30. Nargi, F., E. Kramer, J. Mezencio, J. Zamparo, C. Whetstone, M. H. V. Van Regenmortel, J. P. Briand, S. Muller, and F. Brown. 1999. Protection of swine from foot-and-mouth disease with one dose of an all-d retro peptide. Vaccine 17:2888-2893.
31. Ninomiya, A., K. Ogasawara, K. Kajino, A. Takada, and H. Kida. 2002. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice. Vaccine 20:3123-3129.
32. Ogra, P. L., D. T. Karzon, F. Righthand, and M. MacGillivray. 1968. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N. Engl. J. Med. 279:893-900.
33. Olive, C., M. R. Batzloff, A. Horváth, A. Wong, T. Clair, P. Yarwood, I. Toth, and M. F. Good. 2002. A lipid core construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies. Infect. Immun. 70:2734-2738.
34. Partidos, C. D., J. Ripley, A. Delmas, O. E. Obeid, A. Denbury, and M. W. Steward. 1997. Fine specificity of the antibody response to a synthetic peptide from the fusion protein and protection against measles virus-induced encephalitis in a mouse model. J. Gen. Virol. 78:3227-3232.
35. Pfaff, E., M. Mussgay, H. O. Bohm, G. E. Schultz, and H. Schaller. 1982. Antibodies against a pre-selected peptide recognize and neutralize foot-and-mouth disease virus. EMBO J. 1:869-874.
36. Roost, H.-P., M. F. Bachmann, A. Haag, U. Kalinke, V. Pliska, H. Hengartner, and R. M. Zinkernagel. 1995. Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity. Proc. Natl. Acad. Sci. USA 92:1257-1261.
37. Rowlands, D. J. 1984. Synthetic peptides in foot and mouth disease vaccine research. Endeavour 8:123-127.
38. Salt, J. S. 1993. The carrier state in foot-and-mouth disease - an immunological review. Br. Vet. J. 149:207-223.
39. Tahoga, O., C. Tami, E. Carrillo, J. I. Nunez, A. Rodriguez, J. C. Saiz, E. Blanco, M. L. Valero, X. Roig, J. A. Camarero, D. Andreu, M. G. Mateu, E. Giralt, E. Domingo, F. Sobrino, and E. L. Palma. 1997. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J. Virol. 71:2606-2614.
40. Wang, C. Y., T. Y. Chang, A. M. Walfield, J. Ye, M. Shen, S. P. Chen, M. C. Li, Y. L. Lin, M. H. Jong, P. C. Yang, N. Chyr, E. Kramer, and F. Brown. 2002. Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 20:2603-2610.
41. Winchell, J. M., H. J. Van Kruningen, and L. K. Silbart. 1997. Mucosal immune response to an HIV C4/V3 peptide following nasal or intestinal immunization of rabbits. AIDS Res. Hum. Retrovir. 13:881-889.
42. Xu-Amano, J., H. Kiyono, R. J. Jackson, H. F. Staats, K. Fujihashi, P. D. Burrows, C. O. Elson, S. Pillai, and J. R. McGhee. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:1309-1320.